United Parks & Resorts Inc. PRKS 深 滬
已收盤 02-06 16:00:00 美东时间
37.03
+0.820
+2.26%
華盛通- 最 高37.435
- 今 開35.35
- 成交量 73.88万股
- 最 低 35.29
- 昨 收 36.21
- 總市值 20.20亿
- 52周最高 58.51
- 市盈率 靜 9.77
- 換手率 1.35%
- 52周最低 29.62
- 委 比 -9.91%
- 總股本 5455.06万
- 歷史最高 76.57
- 量 比 0.36
- 振 幅 5.92%
- 歷史最低 6.75
- 每 手 1
- 風險率 6.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Citigroup Maintains Neutral on United Parks & Resorts, Lowers Price Target to $39
Citigroup analyst James Hardiman maintains United Parks & Resorts (NYSE:PRKS) with a Neutral and lowers the price target from $40 to $39.
02-07 02:45
United Parks And Resorts Inc. to Release Fourth Quarter and Fiscal 2025 Financial Results
United Parks And Resorts Inc. to Release Fourth Quarter and Fiscal 2025 Financial Results United Parks & Resorts Inc. (NYSE: PRKS) will release its fourth quarter and fiscal 2025 financial results before the market opens on Thursday, February 26, 2026. The results will be available on the Company's
01-23 05:30
SeaWorld Unveils a Coast-to-Coast Live Music Series for 2026
A nationwide concert lineup brings high-energy performances and crowd-pleasing artists to SeaWorld parks from spring through summer, included with park admission ORLANDO, Fla. and SAN DIEGO ...
01-15 00:00
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
2025-12-05 08:35
Truist Securities Maintains Buy on United Parks & Resorts, Lowers Price Target to $47
Truist Securities analyst Michael Swartz maintains United Parks & Resorts (NYSE:PRKS) with a Buy and lowers the price target from $61 to $47.
2025-12-05 00:27
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
2025-11-13 09:58
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
2025-11-12 11:43
United Parks & Resorts shares are trading lower after the company reported worse-than-expected Q3 financial results.
United Parks & Resorts shares are trading lower after the company reported ...
2025-11-06 20:55
United Parks & Resorts Q3 EPS $1.61 Misses $2.27 Estimate, Sales $511.900M Miss $537.361M Estimate
United Parks & Resorts (NYSE:PRKS) reported quarterly earnings of $1.61 per share which missed the analyst consensus estimate of $2.27 by 29.17 percent. This is a 22.6 percent decrease over earnings of $2.08 per share
2025-11-06 19:31
United Parks & Resorts Approves $500M Share Buyback
An update from United Parks & Resorts ( ($PRKS) ) is now available. On Sept...
2025-09-05 21:28
